NEW YORK – Sysmex America announced Tuesday that it will start selling hemostasis reagents and instruments to laboratories in the US this month.
The products will be sold under the firm's original equipment manufacturer agreement with Siemens Healthineers, which allows each company to distribute Sysmex's hemostasis instruments and Siemens' hemostasis reagents under their respective brands, Sysmex said in a statement. Both firms will market their hemostasis products independently of each other.
Sysmex and Siemens first entered into a global agreement on distribution, sales, and services for hemostasis products in 1995.
"Sysmex has been innovating hemostasis analyzers for more than 30 years, offering complete, easy-to-use hemostasis solutions for laboratories of all sizes and complexities," Sysmex America President and CEO Andy Hay said in a statement. "A trusted reagent portfolio, coupled with the service you expect from Sysmex, ensures that the integration of hemostasis into laboratories will be a pain-free experience."